About Elekta
Elekta is a world-leading supplier of advanced and innovative radiation
oncology and neurosurgery solutions and services for precise treatment of
cancer and brain disorders .

pheromones anosmia

Elekta Reinforces Leadership Position in Neurosurgery at AANS

(Photo: http: //www. operations of the
Elekta Group. Speakers will share how they are constructing a
mechanistic understanding of why these disorder happen, and what work is being
done to discover new targets for potential drugs and therapies.

For sites about the senses of smell (olfaction) and taste.

perceive regimens

anosmia smell

com .

doron receptors

com/cgi-bin/prnh/20020318/ELEKTALOGO )
Scott Hamilton, a four-time U.

ViroLogic Announces Presentations at the 96th Annual Meeting of the American Association for Cancer Research (AACR)

(Nasdaq: VLGC) announced today that four presentations related to its
eTag technology will be made at the 96th Annual Meeting of the American
Association for Cancer Research (AACR), taking place April 16-20 in Anaheim,
California.mit.

smells pheromones

S."
Elekta will display its fourth generation Leksell Gamma Knife(R) at AANS,
as well as the revolutionary Elekta Synergy(R) S, the ideal extracranial
counterpart to Leksell Gamma Knife(R). With a growing number of radiation oncology and neurosurgery
centers treating patients with Leksell Gamma Knife(R) and Elekta Synergy(R),
Elekta proves it is a company that continues to make a difference in the lives
of patients today and in the future. CAMBRIDGE, Mass.

receptor irritation

virologic .

Also acceptable in this category are sites of medical professionals that specialize in treating these senses.

olfactory pheromones

SOUTH SAN FRANCISCO, Calif. In addition, ViroLogic believes these assays
will be used to help physicians better determine whether certain therapies are
more appropriate for individual cancer patients, and whether to combine
therapies with different mechanisms or properties.
Designed for senior researchers, managers and corporate strategists from
the life sciences and healthcare industries, the 2006 MIT Life Sciences
Conference will focus on brain disorders at both ends of the lifespan:
developmental brain disorders, such as autism, and degenerative brain
disorders, such as stroke, Alzheimer's and Parkinson's disease. For more information
please see the ILP Web site at http://ilp-www.

perceive taste

National Champion, four-time World
Champion and Olympic Gold Medalist will be hosted by Elekta, and will speak to
attendees about his battle with testicular cancer in 1997 and his more recent
diagnosis of craniopharnigioma, a rare, non-cancerous pituitary brain tumor.

etiology exert

For additional information about Elekta, please visit http://www.
Scheduled presentations include: "Imaging the Brain: Basis and Treatment
of Development Disorders," "Emotional Memory: Effects of Aging and Alzheimer's
Disease," "Genes That Change Your Mind," "From Fragments to Objects:
Mechanisms of Visual Integration and Their Dysfunction," "Functional
Specificity in the Brain: People, Places + Things," "Alzheimer's Disease - A
Unifying Hypothesis," "Basal Ganglia and Neurological Disorders ,"
"Genetically-Based Strategies for Therapeutic Intervention in Huntington's
Disease," "Robotics for Neuro-Rehabilitation," "Therapeutic Implications of
the mGluR Theory of Fragile X," "Brain Development and Its Importance in
Neurological Dysfunction," and "Toward Molecular Imaging of Neural Circuit
Dynamics.

proactively otolaryngology

"The clinical
track record documented by over 300,000 patient treatments, 217 highly
successful Gamma Knife(R) installations globally, and over 2,000 clinical
publications make radiosurgery ideal for critical brain surgery," Rose said. Elekta's solutions are clinically effective, cost
efficient and gentle to the patient. More information about the Company and its technology can be
found on its web site at http://www.

About the MIT Industrial Liaison Program
The Industrial Liaison Program (ILP) is industry's chief gateway to MIT,
enabling companies worldwide to harness MIT resources to address current
challenges and to anticipate future needs.

diagnoses doron

MIT Neuroscience Conference March 14 to Showcase Developing Technologies for Brain Disorders Disease

taste chemosensory

mit. The ILP helps company managers
monitor MIT research developments, identify and arrange expert consultations
with MIT faculty, license MIT-owned intellectual property, and facilitate
corporate objectives through sponsored research at MIT.

diagnoses perceive

Elekta recently completed its acquisition of IMPAC Medical Systems, Inc.

Details are as follows:

Presentation Time: Monday, April 18, 8:00 am - 12:00 pm
Presentation Number: 2309
Cellular Responses to PI3K/AKT and MAPK Pathway Inhibition in Melanoma

Presentation Time: Tuesday, April 19, 8:00 am - 12:00 pm
Presentation Number: 3688
Correlation of ErbB Activation Status and Clinical Response to Herceptin
Treated Breast Cancer Patients

Presentation Time: Tuesday, April 19, 1:00 pm - 5:00 pm
Presentation Number: 4567
IC50 Determination for Receptor-Targeted Compounds and Downstream
Signaling

Presentation Time: Wednesday, April 20, 8:00 am - 12:00 pm
Presentation Number: 5762
Multiplexed Assay for Assessing ErbB/HER Receptor Pathways in Formalin-
fixed and Paraffin-embedded Cancer Cell Lines

About the eTag System
ViroLogic's eTag assays enable detailed analysis of protein drug targets
and signaling pathways in cancer cells, including samples that are
formalin-fixed, paraffin-embedded, which is the standard format in most
pathology labs.

distorted smells

proactively regimens

About ViroLogic
ViroLogic is a biotechnology company advancing individualized medicine by
discovering, developing and marketing innovative products to guide and improve
treatment of serious infectious diseases and cancer.com.
"The day and a half conference agenda will provide a glimpse of the
technologies available at MIT for what is clearly the next great frontier of
biotechnology -- brain diseases and disorders," said Mriganka Sur, Sherman
Fairchild Professor of Neuroscience and head of MIT's department of brain and
cognitive sciences .

regimens adherence

, Following the opening of MIT's
Brain and Cognitive Science Complex (BCS) last December, researchers and
faculty at the world's largest neuroscience research center will showcase
recent innovations and developing technologies at the 2006 MIT Life Sciences
Conference: Challenges and Opportunities in Neuroscience, scheduled for March
14-15.edu/events/LifeSciences2006/.

Sites specifically about anosmia (the loss or impairment of the sense of smell) should be submitted to the Anosmia subcategory .

adherence pheromones

The company's North American headquarters
are located in Atlanta and corporate headquarters are in Stockholm, Sweden.elekta."
More information on the conference, including complete agenda and
abstracts, can be found at http://ilp-www.

olfaction otolaryngology

and head of the U. The Company's products
are designed to help doctors optimize treatment regimens for their patients
that lead to better outcomes and reduced costs. The Company's technology is
also being used by numerous biopharmaceutical companies to develop new and
improved antiviral therapeutics and vaccines as well as targeted cancer
therapeutics.

Contact:
The MIT Industrial Liaison Program

Michael Lawson
617-452 -3053

regimens taste

Hamilton is noted for his inspirational talks on his life and
achievements , as well as his humanitarian work with cancer organizations. "Other vendors force physicians to compromise , using
an 'all-in-one' radiotherapy solution that has been modified for use in
treating the brain . Together, Elekta and
IMPAC form the world's most comprehensive cancer management company and the
largest supplier of cancer management software.

irritation chemosensory

"Hundreds of thousands of people have been treated with Gamma
Knife(R) surgery, and he epitomizes the patient who can benefit from non-
invasive stereotactic radiosurgery using Gamma Knife(R) surgery, which offers
unmatched accuracy and precision .

olfaction perceive

He was treated with Gamma Knife(R) surgery at the Cleveland Clinic on December
13, 2004. In North America, IMPAC's
systems are installed in over 1,300 oncology centers, over 1,100 cancer
registry operations and over 400 pathology laboratories., ViroLogic,
Inc.

anosmia adherence

World Champion Skater Scott Hamilton will speak in Elekta's booth on his
treatment for a brain tumor using Gamma Knife(R) surgery

ATLANTA, Neurosurgeons attending AANS in New
Orleans April 16-21 will be able to hear an Olympic Gold Medalist speaking
about the industry's Gold Standard for stereotactic radiosurgery , Leksell
Gamma Knife(R) from Elekta.newscom.
"We are delighted that Scott Hamilton can join us at AANS and share his
experiences as a patient with medical professionals who routinely administer
life-saving treatments using Leksell Gamma Knife(R)," said Anthony De Carolis,
President and CEO of Elekta, Inc."
Gamma Knife(R) surgery, or stereotactic radiosurgery, is a single-session
surgical procedure performed by a neurosurgeon / radiation oncologist team
using ultra-precise focused radiation to destroy the target.,
the leading provider of oncology management software. The assays can provide information on a drug's mechanism of
action, selectivity and potency in a biological setting in pre -clinical
research, and enable enrichment or selection of clinical trial populations
later in a drug's development.edu/.

diagnoses irritation

"Elekta is unique in providing both stereotactic radiosurgery and
radiotherapy solutions to optimize treatments, outcomes, and efficiencies with
dedicated, disease-specific solutions " explained Jim Rose, Vice President of
North America Marketing.

Fighting Serious Disease
The strength of Elekta's broad range of specialized neurosurgical
treatment solutions provides a solid market position, which is strengthened
with the introduction of leading edge, emerging clinical applications of
technology.